Immune-mediated colitis: A class effect with anti-CD2O agents used to treat MS?

Vittorio Viti; Chiara Zanetta; Maria A. Rocca; Massimo Filippi

doi:10.1177/13524585241303480

Related publications

Article1989

Interactions <i>in vitro</i> between agents used to treat melioidosis

David A. B. Dance, Vanaporn Wuthiekanun, Wipada Chaowagul, Sir Nicholas White

Journal of Antimicrobial Chemotherapy

Chapter in a book2004

Anti-HIV agents to be used in drug combination regimens

De Clercq Erik

Article1988

Phosphonylmethoxyethyl purine derivatives, a new class of anti-human immunodeficiency virus agents

Rudi Pauwels, Jan Balzarini, Dominique Schols, Masanori Baba, Jan Desmyter, Ivan Rosenberg, Antonı́n Holý, De Clercq Erik

Article2024

Novel endoscopic scoring system for immune mediated colitis: A Multicenter Retrospective Study of 674 Patients

Yinghong Wang, Hamzah Abu‐Sbeih, Tenglong Tang, Malek Shatila, David M. Faleck, Jessica Harris, Michael Dougan, Anna Olsson‐Brown, Douglas B. Johnson, Chanjuan Shi, Petros Grivas, Leonidas Nikolaos Diamantopoulos, Dwight H. Owen, Clarissa A. Cassol, Christina A. Arnold, David E. Warner, Ajjai Alva, Nick Powell, Hajir Ibraheim, Enrico N. De Toni, Alexander Philipp, Jessica Philpott, Joseph Sleiman, Mark P. Lythgoe,

Article2023

Intravascular laser irradiation of blood (ILIB) used to treat lung diseases: a short critical review

Adriana Schapochnik, Paula Tatiane Alonso, Vanessa de Souza, Virgínia Mendes Matias Rodrigues, Kelly Quintela, Marlon da Palma Cruz, Caroline M. Ferreira, Rebeca Boltes Cecatto, Maria Fernanda Setúbal Destro Rodrigues, Michael R Hamblin, Adriana Lino‐dos‐Santos‐Franco